Leaderboards/Neurotransmitter Receptor Influence on Behavior

Neurotransmitter Receptor Influence on Behavior

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Maxemiliano V. Vargas
Multidisciplinary Association for Psychedelic Studies
2
Rafael Moliner
University of Helsinki
3
Ling-Xiao Shao
Cornell University
4
Manoj K. Doss
Johns Hopkins University
5
Richard E. Daws
Wellcome Centre for Human Neuroimaging
6
Natalie Hesselgrave
University of Maryland, Baltimore
7
Dongmei Cao
Center for Excellence in Molecular Cell Science
8
Ling-Xiao Shao
Cornell University
9
Jinxia Wan
Chinese Institute for Brain Research
10
Mario de la Fuente Revenga
Virginia Commonwealth University

Papers

1
Advances in structure-based drug design: The potential for precision therapeutics in psychiatric disorders
Neuron|2024
26 cit.
2
Psilocybin and 2C-B at Encoding Distort Episodic Familiarity
Biological Psychiatry Cognitive Neuroscience and Neuroimaging|2024
7 cit.
3
Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study
Journal of Psychopharmacology|2024
5 cit.
4
Snapshot IP <sub>1</sub> Detection Following 5-HT <sub>2</sub> A Receptor Stimulation in the Mouse Brain
ACS Chemical Neuroscience|2026
1 cit.
5
1. Psilocybin and 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) at Encoding Distort Episodic Familiarity and Positively Bias Emotional Metamemory
Biological Psychiatry|2024
0 cit.
6
STX-bpc: “Brightening” the path to neuronal inhibition
Cell chemical biology|2024
0 cit.
7
Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 2 approved with reservations]
Faculty of 1000 Research Ltd|2024
0 cit.
8
<i>R</i> -MDDMA is a Safer Analogue of MDMA with Therapeutic Potential
ACS Chemical Neuroscience|2026
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Stephan Lammel
University of California, Berkeley
2
Jordi Bonaventura
Bellvitge University Hospital
3
Ilana B. Witten
Princeton University
4
Sheng Wang
Chinese Academy of Sciences
5
Lee E. Dunlap
Multidisciplinary Association for Psychedelic Studies
6
Chunyang Dong
Neurosciences Institute
7
Lin Tian
Shriners Hospitals for Children - Northern California
8
Jianjun Cheng
Anhui Normal University
9
Frederick S. Barrett
Johns Hopkins University
10
Anna K. Radke
Miami University

Papers

1
Structure-based discovery of nonhallucinogenic psychedelic analogs
Science|2022
305 cit.
2
Opponent control of behavior by dorsomedial striatal pathways depends on task demands and internal state
Nature Neuroscience|2022
114 cit.
3
Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature
Current topics in behavioral neurosciences|2022
88 cit.
4
A brain-wide map of neural activity during complex behaviour
Nature|2025
72 cit.
5
A computational analysis of mouse behavior in the sucrose preference test
Nature Communications|2023
60 cit.
6
State and rate-of-change encoding in parallel mesoaccumbal dopamine pathways
Nature Neuroscience|2024
55 cit.
7
Unlocking opioid neuropeptide dynamics with genetically encoded biosensors
Nature Neuroscience|2024
54 cit.
8
Choice-selective sequences dominate in cortical relative to thalamic inputs to NAc to support reinforcement learning
Cell Reports|2022
52 cit.
9
An inhibitory brainstem input to dopamine neurons encodes nicotine aversion
Neuron|2022
50 cit.
10
Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search
Molecular Psychiatry|2022
44 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Eric J. Nestler
Allen Institute for Brain Science
2
George F. Koob
American Society of Addiction Medicine
3
Trevor W. Robbins
University of Cambridge
4
Peter W. Kalivas
Medical University of South Carolina
5
Barry J. Everitt
University Hospitals Sussex NHS Foundation Trust
6
Marc G. Caron
Duke University
7
Solomon H. Snyder
Johns Hopkins University
8
G. Di Chiara
University of Cagliari
9
Dennis L. Murphy
Nassau University Medical Center
10
Daniel R. Weinberger
Johns Hopkins University

Papers

1
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
Science|1996
5.2k cit.
2
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
Proceedings of the National Academy of Sciences|1988
4.7k cit.
3
The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function
Cell|2003
3.9k cit.
4
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Archives of General Psychiatry|1987
3.7k cit.
5
Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.
Proceedings of the National Academy of Sciences|1990
3.3k cit.
6
Drug Abuse: Hedonic Homeostatic Dysregulation
Science|1997
2.5k cit.
7
Effect of COMT Val <sup>108/158</sup> Met genotype on frontal lobe function and risk for schizophrenia
Proceedings of the National Academy of Sciences|2001
2.4k cit.
8
Opiate Receptor: Demonstration in Nervous Tissue
Science|1973
2.4k cit.
9
Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
Nature|1991
2.4k cit.
10
Serotonin Transporter Genetic Variation and the Response of the Human Amygdala
Science|2002
2.3k cit.

Reagents for Neurotransmitter Receptor Influence on Behavior

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

Phospho-SEK1/MKK4 (Thr261) Antibody

Cited in 15 papers
#9151$362
View Evidence →
Cell Signaling Technology

CD6 (E9Q1V) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 15 papers
#81297$865
View Evidence →
Cell Signaling TechnologyEvidence 67

Akt (pan) (C67E7) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 350 Conjugate)

Cited in 13 papers
#38393$458
View Evidence →

🌟 All-Time

Most validated

Millipore

Anti-Dopamine Transporter Antibody, NT, clone DAT-Nt

Cited in 29 papers
#MAB369
View Evidence →
Cell Signaling TechnologyEvidence 63

eIF4GI (D6A6) Rabbit Monoclonal Antibody

Cited in 27 papers
#8701$161,351
View Evidence →
Cell Signaling TechnologyEvidence 63

Phospho-c-Fos (Ser32) (D82C12) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

Cited in 26 papers
#8709$493
View Evidence →